Glucose-dependent Insulinotropic Polypeptide Receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 52: | Line 52: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
[[7dty]] – hGDIPR (mutant) + gastric inhibitory polypeptide + guanine nucleotide-binding protein + nanobody | [[7fiy]] – hGDIPR (mutant) + gastric inhibitory polypeptide + guanine nucleotide-binding protein – human – Cryo EM<br /> | ||
[[7ra3, [[7rbt]] – hGDIPR + gastric inhibitory polypeptide + guanine nucleotide-binding protein + nanobody + ScfV – Cryo EM<br /> | |||
[[7dty]], [[7fin]], [[7vab]] – hGDIPR (mutant) + gastric inhibitory polypeptide + guanine nucleotide-binding protein + nanobody – Cryo EM<br /> | |||
[[2qkh]] - hGDIPR extracellular domain 29-138 + GIP <br /> | [[2qkh]] - hGDIPR extracellular domain 29-138 + GIP <br /> | ||
[[4hj0]], [[6dkj]] - hGDIPR extracellular domain + antibody <br /> | [[4hj0]], [[6dkj]] - hGDIPR extracellular domain + antibody <br /> | ||